» Articles » PMID: 21103183

Commentary on N. Ghaemi's "Hippocratic Psychopharmacology of Bipolar Disorder" Treating Bipolar Disorder: For the Patient or Against the Illness?

Overview
Specialty Psychiatry
Date 2010 Nov 25
PMID 21103183
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This is a commentary on Hippocratic Psychopharmacology in Bipolar Disorder, an article by S. Nasir Ghaemi in this issue of Psychiatry 2006.

Design: Based on Dr. Ghaemi's article and relevant literature, I discuss implications of Hippocratic treatment, i.e., the principle of treating an underlying illness using methods that enhance the patient's adaptive responses, rather than using symptomatic treatments.

Results And Discussion: Key points include 1) the course of illness, as heterogeneous as it is, seems to have episodic-stable and inherently unstable forms; 2) course of illness interacts with episode characteristics, with mixed or polyphasic episodes associated with an unstable and complicated course of illness; 3) consequences in terms of treatment response, with lithium being more effective in treating the episodic-stable than the unstable form of the illness; and 4) the fact that, in determining treatment response, course of illness trumps episode characteristics. The goal of Hippocratic/Oslerian medicine, curative treatment aimed at underlying mechanisms of disease, is the aim of treatment, but is still elusive.

Citing Articles

Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.

Tsai A, Rosenlicht N, Jureidini J, Parry P, Spielmans G, Healy D PLoS Med. 2011; 8(5):e1000434.

PMID: 21559324 PMC: 3086871. DOI: 10.1371/journal.pmed.1000434.

References
1.
Fieve R, Kumbaraci T, Dunner D . Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry. 1976; 133(8):925-9. DOI: 10.1176/ajp.133.8.925. View

2.
Suppes T, Baldessarini R, Faedda G, Tohen M . Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991; 48(12):1082-8. DOI: 10.1001/archpsyc.1991.01810360046007. View

3.
Calabrese J, Vieta E, El-Mallakh R, Findling R, Youngstrom E, Elhaj O . Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry. 2004; 56(12):957-63. DOI: 10.1016/j.biopsych.2004.09.022. View

4.
Gyulai L, Bowden C, McElroy S, Calabrese J, Petty F, Swann A . Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology. 2003; 28(7):1374-82. DOI: 10.1038/sj.npp.1300190. View

5.
Himmelhoch J, Garfinkel M . Sources of lithium resistance in mixed mania. Psychopharmacol Bull. 1986; 22(3):613-20. View